A Potent Kalihinol Analogue Disrupts Apicoplast Function and Vesicular Trafficking in P. falciparum Malaria.
Chahine, Z. M.; Abel, S.; Hollin, T.; Chung, J. H.; Barnes, G. L.; Daub, M. E.; Renard, I.; Choi, J. Y.; Vydyam, P.; Chattopadhyay Pal, A.; Argomaniz, M.; Banks, C.; kirkwood, J.; Saraf, A.; Camino Diaz, I.; Castaneda-Casado, P.; Cuevas-Martin, M.; De Mercado-Arnanz, J.; Fernandez Alvaro, E.; Garcia-Perez, A.; Ibarz-Ferrer, N.; Viera-Morilla, S.; Prudhomme, J.; Joyner, C. J.; Bei, A.; Florens, L.; Ben Mamoun, C.; Vanderwal, C.; Le Roch, K. G.
Show abstract
Here we report the discovery of MED6-189, a new analogue of the kalihinol family of isocyanoterpene (ICT) natural products. MED6-189 is effective against drug-sensitive and-resistant P. falciparum strains blocking both intraerythrocytic asexual replication and sexual differentiation. This compound was also effective against P. knowlesi and P. cynomolgi. In vivo efficacy studies using a humanized mouse model of malaria confirms strong efficacy of the compound in animals with no apparent hemolytic activity or apparent toxicity. Complementary chemical biology, molecular biology, genomics and cell biological analyses revealed that MED6-189 primarily targets the parasite apicoplast and acts by inhibiting lipid biogenesis and cellular trafficking. Genetic analyses in P. falciparum revealed that a mutation in PfSec13, which encodes a component of the parasite secretory machinery, reduced susceptibility to the drug. The high potency of MED6-189 in vitro and in vivo, its broad range of efficacy, excellent therapeutic profile, and unique mode of action make it an excellent addition to the antimalarial drug pipeline. Editors SummaryHere we report the mode of action and mechanism of resistance of a pan-antimalarial agent, MED6-189, which disrupts apicoplast function and vesicular trafficking in P. falciparum.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Gene drive mosquitoes can aid malaria elimination by retarding Plasmodium sporogonic development 95%
- An acyclic nucleoside phosphonate effectively blocks the egress of the malaria parasite by inhibiting the synthesis of cyclic GMP. 94%
- A machine learning approach to define antimalarial drug action from heterogeneous cell-based screens 93%
Similar papers in this journal
- A pyridyl-furan series developed from Open Global Health Library blocks red blood cell invasion and protein trafficking in Plasmodium falciparum through potential inhibition of the parasites PI4KIIIb enzyme. 96%
- Mammalian deubiquitinating enzyme inhibitors display in vitro and in vivo activity against malaria parasites and potentiate artemisinin action 95%
- Identification of α-azacyclic acetamide-based inhibitors of P. falciparum Na+ pump (PfATP4) with fast-killing asexual blood-stage antimalarial activity by phenotypic screening 95%
Similar papers in this journal
Similar papers in this journal
- Screening the Pathogen Box Compounds for Activity Against Plasmodium falciparum Sporozoite Motility 96%
- Activity of epigenetic inhibitors against Plasmodium falciparum asexual and sexual blood stages. 96%
- Atypical molecular basis for drug resistance to mitochondrial function inhibitors in Plasmodium falciparum 96%
Similar papers in this journal
- Evolution of resistance in vitro reveals a novel mechanism of artemisinin activity in Toxoplasma gondii. 95%
- Direct Tests of Cytochrome Function in the Electron Transport Chain of Malaria Parasites 95%
- Identification of a divalent metal transporter required for cellular iron metabolism in malaria parasites 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.